Back
Ionis Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
34
IONS
Ionis Pharmaceuticals
Last Price:
34.15
Seasonality Move:
4.86%
Sell
23
ALNY
Alnylam Pharmaceuticals
Last Price:
245.93
Seasonality Move:
10.85%
Sell
34
Ionis Pharmaceuticals (IONS)
is a Sell
Is Ionis Pharmaceuticals a Buy, Sell or Hold?
- The current Ionis Pharmaceuticals [IONS] share price is $35.40. The Score for IONS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- IONS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $248.79. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IONS Stock Price Chart
What is Ionis Pharmaceuticals's stock price today?
-
The Ionis Pharmaceuticals share price today is $35.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IONS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $248.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
IONS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.31 | Sell |
Relative Strength Index (14 RSI): | 37.41 | Sell |
Chaikin Money Flow: | 1790884 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.3 - 39.88) | Sell |
Bollinger Bands (100): | (38.71 - 48.31) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.64 | Sell |
Relative Strength Index (14 RSI): | 39.68 | Sell |
Chaikin Money Flow: | 997085 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (254.01 - 292.55) | Sell |
Bollinger Bands (100): | (248.69 - 281.73) | Sell |
IONS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.11 | Sell |
20-day SMA: | 37.86 | Sell |
50-day SMA: | 39.09 | Sell |
200-day SMA: | 43.03 | Sell |
8-day EMA: | 35.8 | Sell |
20-day EMA: | 37.26 | Sell |
50-day EMA: | 39.39 | Sell |
200-day EMA: | 42.65 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 252.75 | Sell |
20-day SMA: | 267.61 | Sell |
50-day SMA: | 273.13 | Sell |
200-day SMA: | 210.87 | Buy |
8-day EMA: | 250.09 | Sell |
20-day EMA: | 262.36 | Sell |
50-day EMA: | 266.92 | Sell |
200-day EMA: | 230.73 | Buy |
Ionis Pharmaceuticals Earnings Growth & IONS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.03 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.
Ionis Pharmaceuticals Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |